Oxidative modulation of nuclear factor-κB in human cells expressing mutant fALS-typical superoxide dismutases

Journal of Neurochemistry

Volumn 83, Issue 5, 2002, Pages 1019-1029

  Casciati, Arianna ^a   Ferri, Alberto ^a,b   Cozzolino, Mauro ^c   Celsi, Fulvio ^a   Nencini, Monica ^d   Rotilio, Giuseppe ^d   Carrì, Maria Teresa ^c,d  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

^c Laboratory di Neurochimica   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Calcineurin; Familial amyotrophic lateral sclerosis; I B ; Nuclear factor B; Superoxide dismutase; Tumor necrosis factor

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOOXYGENASE 2; CYCLOPHILIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; VALSPODAR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOTOR NEURON DISEASE; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; BLOTTING, WESTERN; CALCINEURIN; CYCLOOXYGENASE 2; CYSTEINE ENDOPEPTIDASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATORS; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; I-KAPPA B PROTEINS; ISOENZYMES; MEMBRANE PROTEINS; MULTIENZYME COMPLEXES; NEUROBLASTOMA; NF-KAPPA B; OXIDATION-REDUCTION; PHOSPHORYLATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

MUS MUSCULUS;

EID: 0036892743     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01232.x     Document Type: Article

References (64)

1. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A. P., Chen C. and Przedborski S. (2001) Increased expression of the proinflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49, 176-185.
2. Bales K. R., Du Y., Dodel R. C., Yan G. M., Hamilton-Byrd E. and Paul S. M. (1998) The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Brain Res. Mol. Brain Res. 57, 63-72.
3. Bogdanov M., Ramos L. E., Xu X. and Beal M. F. (1998) Elevated 'hydroxyl radical' generation in vivo in an animal model of Amyotrophic Lateral Sclerosis. J. Neurochem. 71, 1321-1324.
4. Bowie A. and O'Neill L. A. (2000) Oxidative stress and nuclear factorkappa B activation: A reassessment of the evidence in the light of recent discoveries. Biochem. Pharmacol. 59, 13-23.
5. Carballo M., Màrquez G., Conde M., Martin-Nieto J., Monteseirinb J., Conde J., Pintado E. and Sobrino F. (1999) Characterization of calcineurin in human neutrophils. J. Biol. Chem. 274, 93-100.
6. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 414, 365-368.
7. Chen B., Christakos S. and Mattson M. P. (1994) Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153.
8. Chen C. C., Chin K. T., Sun Y. T. and Chen W. C. (1999) Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J. Biol. Chem. 274, 31559-31564.
9. Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H. and Ballard D. W. (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP 2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94, 10057-10062.
10. Ciriolo M. R., De Martino A., Lafavia E., Rossi L., Carrì M. T. and Rotilio G. (2000) Cu,Zn superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275, 5065-5072.
11. Cleveland D. W. (1999) From Charcot to SOD1: Mechanisms of selective motor neuron death in ALS. Neuron 24, 515-520.
12. Corson L. B., Strain J. J., Culotta V. C. and Cleveland D. W. (1998) Chaperone-facilitated copper binding is a property common to several classes of familial amyiotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. USA 95, 6361-6366.
13. Drachman D. B. and Rothstein J. D. (2000) Inhibition of cyclooxygenase-2 protect motor neuron in an organotypic model of amyotrophic lateral sclerosis. Ann. Neurol. 48, 792-795.
14. Estevez A. G., Crow J. P., Sampson J. B., Reiter C., Zhuang Y., Richardson G. J., Tarpey M. M., Barbeito L. and Beckman J. S. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286, 2498-2500.
15. Ferrante R. J., Browne S. E., Shinobu L. A., Bowling A. C., Baik M. J., MacGarvey U., Kowall N. W., Brown R. H. Jr and Beal M. F. (1997) Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 69, 2064-2074.
16. Ferri A., Gabbianelli R., Casciati A., Paolucci E., Rotilio G. and Carri M. T. (2000) Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosissuperoxide dismutase. J. Neurochem. 75, 606-613.
17. Ferri A., Gabbianelli R., Casciati A., Celsi F., Rotilio G. and Carrì M. T. (2001) Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis. J. Neurochem. 79, 531-538.
18. Gabbianelli R., Ferri A., Rotilio G. and Carrì M. T. (1999) Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis. J. Neurochem. 73, 1175-1180.
19. 2-dependent activation of nuclear factor κB. J. Biol. Chem. 276, 8918-8923.
20. Ghadge G. D., Lee J. P., Bindokas V. P., Jordan J., Ma L., Miller R. J. and Roos R. P. (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 8756-8766.
21. Hans Y., Weinman S., Boldogh I., Walker R. K. and Brasier A. R. (1999) Tumor necrosis factor-α inducible IκBα proteolysis mediated by cytosolic m-calpain. J. Biol. Chem. 274, 787-794.
22. Hayward L. J., Rodriguez J. A., Kim J. W., Tiwari A., Goto J. J., Cabelli D. E., Valentine J. S. and Brown R. H. Jr (2002) Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial ALS. J. Biol. Chem. 277, 15923-15931.
23. Hottinger A. F., Fine E. G., Gurney M. E., Zurn A. D. and Aebscher P. (1997) The copper chelator D-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9, 1548-1551.
24. Hunot S., Brugg B., Ricard D., Michel P. P., Muriel M. P., Ruberg M., Faucheux B. A., Agid Y. and Hirsch E. C. (1997) Nuclear translocation of NF-κB is increased in domaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531-7536.
25. Jobin C., Morteau O., Han D. S. and Balfour Sartor R. (1998) Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1 gene expression in HT-29 cells. Immunology 95, 537-543.
26. Julien J.-P. (2001) Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded. Cell 104, 581-591.
27. Kaltschmidt B., Uherek M., Volk B., Baeuerle P. A. and Kaltschmidt C. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid-α peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
28. Karin M. and Ben-Neriah Y. (2000) Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663.
29. Koulich E., Nguyen T., Johnson K., Giardina C. A. and D'Mello S. R. (2001) NF-κB is involved in the survival of cerebellar granule neurons: Association of IκB phosphorylation with cell survival. J. Neurochem. 76, 1188-1198.
30. Laemmli U.K. (1972) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-689.
31. Lee S. J., Hou J. and Benveniste E. N. (1998) Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-κB and C/EBPisoforms. J. Neuroimmuno. 92, 196-207.
32. Lee M.-H., Hyum D.-H., Halliwell B. and Jenner P. (2001) Effect of overexpression of wild-type and mutant Cu,Zn superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: Potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2. J. Neurochem. 78, 209-220.
33. Liu D., Wen J., Liu J. and Li L. (1999) The roles of free radicals in amyotrophic lateral sclerosis: Reactive oxygen species and elevated oxidation of protein, DNA and membrane phospholipids. FASEB J. 13, 2318-2328.
34. Mattson M. P. and Camandola S. (2001) NF-kappa B in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254.
35. Mattson M. P., Goodman Y., Luo H., Fu W. and Furukawa K. (1997) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697.
36. McEchem G., Kassovska-Bratinova S., Raha S., Tamopolsky M. A., Turnbull J., Bourgeois J. and Robinson B. (2000) Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines. Biochem. Biophys. Res. Commun. 273, 359-363.
37. Migheli A., Piva R., Atzori C., Troost D. and Schiffer D. (1997) C-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 56, 1314-1322.
38. Mirza A., Liu S. L., Frizell E., Zhu J., Maddukuri S., Martinez J., Davies P., Schwarting R., Norton P. and Zem M. A. (1997) A role for tissue transglutaminase in hepatic injury and fibrogenesis and its regulation by NF-κB. Am. J. Physiol. 272, G281-G288.
39. Morioka M., Hamada J. I., Ushio Y. and Miyamoto E. (1999) Potential role of calcineurin for brain ischemia and traumatic injury. Prog. Neurobiol. 58, 1-30.
40. Pierce R. H., Campbell J. S., Stephenson A. B., Franklin C. C., Chaisson M., Poot M., Rabinovitch P. S. and Fausto N. (2000) Disruption of redox homeostasis in tumor necrosis factor induced apoptosis in murine hepatocyte cell line. Am. J. Pathol. 157, 221-236.
41. Poligone B. and Baldwin A. S. (2001) Positive and negative regulation of NF-κB by COX-2. J. Biol. Chem. 276, 38658-38664.
42. Poloni M., Facchetti D., Mai R., Micheli A., Agnoletti L., Francolini G., Mora G., Camana C., Mazzini M. and Bachetti T. (2000) Circulating levels of tumor necrosis factor-α and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 287, 211-214.
43. Pons S. and Torres-Aleman I. (2000) Insulin-like growth factor-I stimulates dephosphorylation of IκB through the serine phosphatase calcineurin (protein phosphatase 2B). J. Biol. Chem. 275, 38620-38625.
44. Qin Z. H., Wang Y., Nakai M. and Chase T. N. (1998) Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum. Mol. Pharmacol. 53, 33-42.
45. Rabizadeh S., Gralla E. B., Borchelt D. R., Gwinn R., Valentine J. S., Sisodia S., Wong P., Lee M., Hahn H. and Bredesen D. E. (1995) Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells. Proc. Natl. Acad. Sci. USA 92, 3024-3028.
46. Ravati A., Alhemeyer B., Becker A., Klumpp S. and Krieglstein J. (2001) Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-κB. J. Neurochem. 78, 909-919.
47. Rodriguez J. A., Valentine J. S., Eggers D. K., Roe J. A., Tiwari A., Brown R. H. Jr and Hayward L. J. (2002) Familial ALS-associated mutations decrease the thermal stability of distinctly metallated species of human copper-zinc superoxide dismutase. J. Biol. Chem. 277, 15932-15937.
48. Roe J. A., Wiedau-Pazos M., Moy V. N., Goto J. J., Gralla E. B. and Valentine J. S. (2002) In vivo peroxidative activity of FALS-mutant human CuZnSODs expressed in yeast. Free Rad. Biol. Med. 32, 169-174.
49. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B. V. D., Bergh R., Hung W. Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R. and Brown R. H. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-61.
50. Rusnak F. and Mertz P. (2000) Calcineurin: Form and function. Physiol. Rev. 80, 1483-1521.
51. Sakurai H., Chiba H., Myoshi H., Sugita T. and Toriumi W. (1999) IκB kinase phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274, 30353-30356.
52. Schmedtje J. F. Jr, Ji Y. S., Liu W. L., Dubois R. N. and Runge M. S. (1997) Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272, 601-608.
53. Schmitz M. L., Bacher S. and Kracht M. (2001) IκB-independent control of NF-κB activity by modulatory phosphorylations. Trends Biochem. Sci. 26, 186-190.
54. Schreck R., Albermann K. and Baeuerle P. A. (1991) Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic. Res. Commun. 17, 221-237.
55. Scorrano L., Penzo D., Petronilli V., Pagano F. and Bernardi P. (2001) Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha apoptotic signaling. J. Biol. Chem. 276, 12035-12040.
56. Sizemore N., Lerner N., Dombrowski N., Sakurai H. and Stark G. R. (2002) Distinct roles of the IκB kinase alpha and beta subunits in liberating nuclear factor Kb (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J. Biol. Chem. 277, 3863-3869.
57. Subramaniam J. R., Lyons W. E., Liu J., Bartnikas T. B., Rothstein J., Price D. L., Cleveland D. L., Gitlin J. D. and Wong P. (2002) Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5, 301-307.
58. Taylor B. S., de Vera M. E., Ganster R. W., Wang Q., Shapiro R. A., Morris S. M. Jr, Billiar T. R. and Geller D. A. (1998) Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273, 15148-15156.
59. Volkel H., Scholz M., Link J., Selzle M., Werner P., Tunnemann R., Jung G., Ludolph A. C. and Reuter A. (2001) Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin. FEBS Lett. 503, 201-205.
60. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S. and Bredesen D. E. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
61. Wong B. S., Liu T., Li R., Pan T., Petersen R. B., Smith M. A., Gambetti P., Perry G., Manson J. C., Brown D. R. and Sy M. S. (2001) Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J. Neurochem. 76, 565-572.
62. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93, 5709-5714.
63. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M. and Sobue G. (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158-167.
64. Zong W. X., Edelstein L. C., Chen C., Bash J. and Gelinas C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis: Genes Dev. 13, 382-387.